Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study

A. Cuneo, G. Follows, G.M. Rigolin, A. Piciocchi, A. Tedeschi, L. Trentin, A.M. Perez, M. Coscia, L. Laurenti, G. Musuraca, L. Farina, A.R. Delgado, E.M. Orlandi, P. Galieni, F.R. Mauro, C. Visco, A. Amendola, A. Billio, R. Marasca, A. ChiarenzaV. Meneghini, F. Ilariucci, M. Marchetti, S. Molica, F. Re, G. Gaidano, M. Gonzalez, F. Forconi, S. Ciolli, A. Cortelezzi, M. Montillo, L. Smolej, A. Schuh, T.A. Eyre, B. Kennedy, K.M. Bowles, M. Vignetti, J. De La Serna, C. Moreno, R. Foà, P. Ghia, GIMEMA Party, European Research Initiative on CLL (ERIC), UK CLL forum

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
Pages (from-to)1209-1217
Number of pages9
JournalHaematologica
Volume103
Issue number7
DOIs
Publication statusPublished - 2018

Cite this

Cuneo, A., Follows, G., Rigolin, G. M., Piciocchi, A., Tedeschi, A., Trentin, L., Perez, A. M., Coscia, M., Laurenti, L., Musuraca, G., Farina, L., Delgado, A. R., Orlandi, E. M., Galieni, P., Mauro, F. R., Visco, C., Amendola, A., Billio, A., Marasca, R., ... forum, UK. CLL. (2018). Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study. Haematologica, 103(7), 1209-1217. https://doi.org/10.3324/haematol.2018.189837